NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
2
Data completeness
1/8 — Limited
Drug data last refreshed 12h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSOL 5% is a protein hydrolysate injectable nutritional product administered intravenously to provide amino acids and protein support. It is indicated for patients requiring parenteral nutrition support who cannot meet nutritional needs orally or enterally. The product delivers essential and non-essential amino acids to support protein synthesis and metabolic function in hospitalized or critically ill patients.
Pre-Launch
Pre-launch stage indicates active build-out of commercial infrastructure; expect hiring across field sales, market access, and launch readiness functions.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Started Sep 2025
75 enrolled
Sarcopenia in ElderlyMalnourishedProtein Supplementation+3 more
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
Started Mar 2011
86 enrolled
Cow Milk Allergy
Career Relevance
Careers on AMINOSOL 5% will focus on hospital and health system relationships, formulary management, and reimbursement given its institutional care context. Pre-launch status presents an opportunity to shape market positioning and build sales infrastructure from inception, but limited clinical expansion potential may cap long-term career growth on the brand.
Worked on AMINOSOL 5% at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.